Brief: OHR Pharmaceutical Announces Stockholder Approval Of Merger Agreement With Neubase Therapeutics
10/07/2019 19:23
July 10 (Reuters) - OHR Pharmaceutical Inc OHRP.O :
* OHR PHARMACEUTICAL, INC. ANNOUNCES STOCKHOLDER APPROVAL OF
MERGER AGREEMENT WITH NEUBASE THERAPEUTICS, INC.
* OHR PHARMACEUTICAL INC - OHR AND NEUBASE EXPECT CLOSING OF
MERGER TO OCCUR DURING WEEK OF JULY 15, 2019
Source text for Eikon: ID:nGNX7yVGRv
Further company coverage: OHRP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet